Citation: Taha Muhammad, Ali Shah Syed Adnan, Afifi Muhammad, Zulkeflee Manar, Sultan Sadia, Wadood Abdul, Rahim Fazal, Ismail Nor Hadiani. Morpholine hydrazone scaffold: Synthesis, anticancer activity and docking studies[J]. Chinese Chemical Letters, ;2017, 28(3): 607-611. doi: 10.1016/j.cclet.2016.10.020 shu

Morpholine hydrazone scaffold: Synthesis, anticancer activity and docking studies

a.
Atta-ur-Rahman Institute for Natural Product Discovery (AuRIns), Universiti Teknologi MARA, Puncak Alam Campus, 42300 Bandar Puncak Alam, Selangor D. E., Malaysia
b.
Faculty of Applied Science, UiTM Shah Alam, 40450 Shah Alam, Selangor D. E., Malaysia
c.
Faculty of Pharmacy, Universiti Teknologi MARA, Puncak Alam Campus, 42300 Bandar Puncak Alam, Selangor D. E., Malaysia
d.
Department of Biochemistry, Abdul Wali Khan University, Mardan 23200, Pakistan
e.
Department of Chemistry, Hazara University, Mansehra 21300, Pakistan

Corresponding author: Taha Muhammad, taha_hej@yahoo.com Ali Shah Syed Adnan, syedadnan@salam.uitm.edu.my
Received Date: 17 June 2016
Revised Date: 22 August 2016
Accepted Date: 12 September 2016
Available Online: 20 March 2016

Figures(2)

In this paper, synthesis and anticancer activities of morpholine hydrazones scaffold (1-17) thoroughly studied. Small series of morpholine hydrazones synthesized by treating 5-morpholinothiophene-2-carbaldehyde with different aryl hydrazides to form morpholine hydrazones scaffold (1-17). The in vitro anticancer potential of all these compounds was checked against human cancer cell lines like HepG2 (human hepatocellular liver carcinoma) and MCF-7 (human breast adenocarcinoma). Analogs 13 had similar substantial cytotoxic effects towards HepG2 with IC₅₀ value 6.31±1.03 μmol/L when compared with the standard Doxorubicin (IC₅₀ value 6.00±0.80 μmol/L); while compounds 5, 8 and 9 showed potent cytotoxicity against MCF-7 with IC₅₀ value 7.08±0.42 μmol/L, 1.26±0.34 μmol/L and 11.22±0.22 μmol/L respectively when compared with the standard Tamoxifen (IC₅₀=11.00±0.40 μmol/L). Molecular docking studies also performed to understand the binding interaction.
- Morpholine hydrazones,
- Synthesis,
- HepG2,
- MCF-7,
- Molecular docking
1. [1]
  Duncan C., White A.R.. Copper complexes as therapeutic agents[J]. Metallomics, 2012,4:127-138. doi: 10.1039/C2MT00174H
2. [2]
  Ang C.Y., Tan S.Y., Zhao Y.L.. Recent advances in biocompatible nanocarriers for delivery of chemotherapeutic cargoes towards cancer therapy[J]. Org. Biomol. Chem., 2014,12:4776-4806. doi: 10.1039/c4ob00164h
3. [3]
  Garza-Ortiz A., Maheswari P.U., Siegler M., Spek A.L., Reedijk J.. A new family of Ru (Ⅱ) complexes with a tridentate pyridine Schiff-base ligand and bidentate co-ligands:synthesis, characterization, structure and in vitro cytotoxicity studies[J]. New J. Chem., 2013,37:3450-3460. doi: 10.1039/c3nj00415e
4. [4]
  Chen W.S., Ou W.Z., Wang L.Q.. Synthesis and biological evaluation of hydroxyl-substituted Schiff-bases containing ferrocenyl moieties[J]. Dalton Trans., 2013,42:15678-15686. doi: 10.1039/c3dt51977e
5. [5]
  Rahman F.U., Ali A., Guo R.. Synthesis and anticancer activities of a novel class of mono-and di-metallic Pt (Ⅱ) (salicylaldiminato) (DMSO or Picolino) Cl complexes[J]. Dalton Trans., 2015,44:2166-2175. doi: 10.1039/C4DT03018D
6. [6]
  Sawyers C.L., Abate-Shen C., Anderson K.C.. AACR cancer progress report 2013[J]. Clin. Cancer Res, 2013,19:S1-S98. doi: 10.1158/1078-0432.CCR-13-2107
7. [7]
  Ribrag V., Dupuis J., Tilly H.. A dose-escalation study of SAR3419, an antiCD19 antibody maytansinoid conjugate, administered by intravenous infusion once weekly in patients with relapsed/refractory B-cell non-Hodgkin lymphoma[J]. Clin. Cancer Res., 2014,20:213-220. doi: 10.1158/1078-0432.CCR-13-0580
8. [8]
  Ghoussaini M., Fletcher O., Michailidou K.. Genome-wide association analysis identifies three new breast cancer susceptibility loci[J]. Nat. Genet., 2012,44:312-318. doi: 10.1038/ng.1049
9. [9]
  Robert N.J., Diéras V., Glaspy J.. RIBBON-1:randomized, double-blind, placebo-controlled, phase Ⅲ trial of chemotherapy with or without bevacizumab for first-line treatment of human epidermal growth factor receptor 2-negative, locally recurrent or metastatic breast cancer[J]. J. Clin. Oncol., 2011,29:1252-1260. doi: 10.1200/JCO.2010.28.0982
10. [10]
  Rosenberg B., Van Camp L., Krigas T.. Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode[J]. Nature, 1965,205:698-699. doi: 10.1038/205698a0
11. [11]
  Sak A., Grehl S., Engelhard M.. Long-term in vivo effects of cisplatin on γ-H2AX foci signaling in peripheral lymphocytes of tumor patients after irradiation[J]. Clin. Cancer Res., 2009,15:2927-2934. doi: 10.1158/1078-0432.CCR-08-0650
12. [12]
  Galluzzi L., Senovilla L., Vitale I.. Molecular mechanisms of cisplatin resistance[J]. Oncogene, 2012,31:1869-1883. doi: 10.1038/onc.2011.384
13. [13]
  Andrs M., Korabecny J., Jun D.. Phosphatidylinositol 3-kinase (PI3K) and phosphatidylinositol 3-kinase-related kinase (PIKK) inhibitors:importance of the morpholine ring[J]. J. Med. Chem., 2015,58:41-71. doi: 10.1021/jm501026z
14. [14]
  Dugave C., Demange L.. Cis-trans isomerization of organic molecules and biomolecules:implications and applications[J]. Chem. Rev., 2003,103:2475-2532. doi: 10.1021/cr0104375
15. [15]
  Arrieta A., Oteagui D., Zubia A.. Solvent-free thermal and microwaveassisted[3+2] cycloadditions between stabilized azomethine ylides and nitrostyrenes. An experimental and theoretical study[J]. J. Org. Chem., 2007,72:4313-4322. doi: 10.1021/jo062672z
16. [16]
  Polak A.. Mode of action of morpholine derivatives[J]. Ann. N. Y. Acad. Sci., 1988,554:221-228.
17. [17]
  A. Kerkenaar, The model of action of dimethylmorpholines, Recent Trends in Discovery, Development and Evaluation of Antifungal Agents, vol. 1, Prous Science Publ., 1987, pp. 523-542.
18. [18]
  R.G.M.P. Pinto, B.V. Silva, A.C. Pinto, Syntheis of convolutamidin analogues, 35th Annual Meeting of the Brazilian Chemical Society (2013).
19. [19]
  Taha M., Ismail N.H., Imran S.. Identification of bisindolylmethane-hydrazone hybrids as novel inhibitors of β-glucuronidase, DFT, and in silico SAR intimations[J]. RSC Adv., 2016,6:3276-3289. doi: 10.1039/C5RA19513F
20. [20]
  Taha M., Ismail N.H., Imran S., Selvaraj M., Rahim F.. Synthesis of novel inhibitors of β-glucuronidase based on the benzothiazole skeleton and their molecular docking studies[J]. RSC Adv., 2016,6:3003-3012. doi: 10.1039/C5RA23072A
21. [21]
  Imran S., Taha M., Ismail N.H.. Synthesis, in vitro and docking studies of new flavone ethers as α-glucosidase inhibitors[J]. Chem. Biol. Drug Des., 2016,87:361-373. doi: 10.1111/cbdd.2016.87.issue-3
22. [22]
  Taha M., Ismail N.H., Imran S.. Hybrid benzothiazole analogs as antiurease agent:synthesis and molecular docking studies[J]. Bioorg. Chem., 2016,66:80-87. doi: 10.1016/j.bioorg.2016.03.010
23. [23]
  Taha M., Ismail N.H., Imran S.. Novel thiosemicarbazide-oxadiazole hybrids as unprecedented inhibitors of yeast α-glucosidase and in silico binding analysis[J]. RSC Adv., 2016,6:33733-33742. doi: 10.1039/C5RA28012E
24. [24]
  Taha M., Ismail N.H., Imran S.. Synthesis, molecular docking and α-glucosidase inhibition of 5-aryl-2-(6'-nitrobenzofuran-2'-yl)-1, 3, 4-oxadiazoles[J]. Bioorg. Chem., 2016,66:117-123. doi: 10.1016/j.bioorg.2016.04.006
25. [25]
  A. Kaapro, J. Ojanen, Protein Docking. Available at http://www.lce.hut.fi/teaching/S-114.500/k2002/Protdock.pdf, 2002.
26. [26]
  Taha M., Ismail N.H., Khan A.. Synthesis of novel derivatives of oxindole, their urease inhibition and molecular docking studies[J]. Bioorg. Med. Chem. Lett., 2015,25:3285-3289. doi: 10.1016/j.bmcl.2015.05.069
27. [27]
  Taha M., Ismail N.H., Imran S.. Novel quinoline derivatives as potent in vitro α-glucosidase inhibitors:in silico studies and SAR predictions[J]. Med. Chem. Comm., 2015,6:1826-1836. doi: 10.1039/C5MD00280J
28. [28]
  Taha M., Ismail N.H., Lalani S.. Synthesis of novel inhibitors of α-glucosidase based on the benzothiazole skeleton containing benzohydrazide moiety and their molecular docking studies[J]. Eur. J. Med. Chem., 2015,92:387-400. doi: 10.1016/j.ejmech.2015.01.009
1. [1]
  Yulong Shi , Fenbei Chen , Mengyuan Wu , Xin Zhang , Runze Meng , Kun Wang , Yan Wang , Yuheng Mei , Qionglu Duan , Yinghong Li , Rongmei Gao , Yuhuan Li , Hongbin Deng , Jiandong Jiang , Yanxiang Wang , Danqing Song . Chemical construction and anti-HCoV-OC43 evaluation of novel 10,12-disubstituted aloperine derivatives as dual cofactor inhibitors of TMPRSS2 and SR-B1. Chinese Chemical Letters, 2024, 35(5): 108792-. doi: 10.1016/j.cclet.2023.108792
2. [2]
  Huiju Cao , Lei Shi . sp¹-Hybridized linear and cyclic carbon chain. Chinese Chemical Letters, 2025, 36(4): 110466-. doi: 10.1016/j.cclet.2024.110466
3. [3]
  Zhi Zhou , Yu-E Lian , Yuqing Li , Hui Gao , Wei Yi . New Insights into the Molecular Mechanism Behind Clinical Tragedies of “Cephalosporin with Alcohol”. University Chemistry, 2025, 40(3): 42-51. doi: 10.12461/PKU.DXHX202403104
4. [4]
  Jiaming Xu , Yu Xiang , Weisheng Lin , Zhiwei Miao . Research Progress in the Synthesis of Cyclic Organic Compounds Using Bimetallic Relay Catalytic Strategies. University Chemistry, 2024, 39(3): 239-257. doi: 10.3866/PKU.DXHX202309093
5. [5]
  Caihong Mao , Yanfeng He , Xiaohan Wang , Yan Cai , Xiaobo Hu . Synthesis and molecular recognition characteristics of a tetrapodal benzene cage. Chinese Chemical Letters, 2024, 35(8): 109362-. doi: 10.1016/j.cclet.2023.109362
6. [6]
  Liyong Ding , Zhenhua Pan , Qian Wang . 2D photocatalysts for hydrogen peroxide synthesis. Chinese Chemical Letters, 2024, 35(12): 110125-. doi: 10.1016/j.cclet.2024.110125
7. [7]
  Shulei Hu , Yu Zhang , Xiong Xie , Luhan Li , Kaixian Chen , Hong Liu , Jiang Wang . Rh(Ⅲ)-catalyzed late-stage C-H alkenylation and macrolactamization for the synthesis of cyclic peptides with unique Trp(C7)-alkene crosslinks. Chinese Chemical Letters, 2024, 35(8): 109408-. doi: 10.1016/j.cclet.2023.109408
8. [8]
  Hongjin Shi , Guoyin Yin , Xi Lu , Yangyang Li . Stereoselective synthesis of 2-deoxy-α-C-glycosides from glycals. Chinese Chemical Letters, 2024, 35(12): 109674-. doi: 10.1016/j.cclet.2024.109674
9. [9]
  Anqiu LIU , Long LIN , Dezhi ZHANG , Junyu LEI , Kefeng WANG , Wei ZHANG , Junpeng ZHUANG , Haijun HAO . Synthesis, structures, and catalytic activity of aluminum and zinc complexes chelated by 2-((2,6-dimethylphenyl)amino)ethanolate. Chinese Journal of Inorganic Chemistry, 2024, 40(4): 791-798. doi: 10.11862/CJIC.20230424
10. [10]
  Kangmin Wang , Liqiu Wan , Jingyu Wang , Chunlin Zhou , Ke Yang , Liang Zhou , Bijin Li . Multifunctional 2-(2′-hydroxyphenyl)benzoxazoles: Ready synthesis, mechanochromism, fluorescence imaging, and OLEDs. Chinese Chemical Letters, 2024, 35(10): 109554-. doi: 10.1016/j.cclet.2024.109554
11. [11]
  Shu-Ran Xu , Fang-Xing Xiao . Metal halide perovskites quantum dots: Synthesis, and modification strategies for solar CO2 conversion. Chinese Journal of Structural Chemistry, 2023, 42(12): 100173-100173. doi: 10.1016/j.cjsc.2023.100173
12. [12]
  Ying Li , Long-Jie Wang , Yong-Kang Zhou , Jun Liang , Bin Xiao , Ji-Shen Zheng . An improved installation of 2-hydroxy-4-methoxybenzyl (iHmb) method for chemical protein synthesis. Chinese Chemical Letters, 2024, 35(5): 109033-. doi: 10.1016/j.cclet.2023.109033
13. [13]
  Zhixiang Li , Zhirong Yang , Chang Yao , Bin Wu , Gang Qian , Xuezhi Duan , Xinggui Zhou , Jing Zhang . Efficient continuous synthesis of 2-hydroxycarbazole and 4-hydroxycarbazole in a millimeter scale photoreactor. Chinese Chemical Letters, 2024, 35(4): 108893-. doi: 10.1016/j.cclet.2023.108893
14. [14]
  Juanjuan Wang , Fang Wang , Bin Qin , Yue Wu , Huan Yang , Xiaolong Li , Lanfang Wang , Xiufang Qin , Xiaohong Xu . Controlled synthesis and excellent magnetism of ferrimagnetic NiFe₂Se₄ nanostructures. Chinese Chemical Letters, 2024, 35(11): 109449-. doi: 10.1016/j.cclet.2023.109449
15. [15]
  Ting Xie , Xun He , Lang He , Kai Dong , Yongchao Yao , Zhengwei Cai , Xuwei Liu , Xiaoya Fan , Tengyue Li , Dongdong Zheng , Shengjun Sun , Luming Li , Wei Chu , Asmaa Farouk , Mohamed S. Hamdy , Chenggang Xu , Qingquan Kong , Xuping Sun . CoSe₂ nanowire array enabled highly efficient electrocatalytic reduction of nitrate for ammonia synthesis. Chinese Chemical Letters, 2024, 35(11): 110005-. doi: 10.1016/j.cclet.2024.110005
16. [16]
  Jiaqi Ma , Lan Li , Yiming Zhang , Jinjie Qian , Xusheng Wang . Covalent organic frameworks: Synthesis, structures, characterizations and progress of photocatalytic reduction of CO2. Chinese Journal of Structural Chemistry, 2024, 43(12): 100466-100466. doi: 10.1016/j.cjsc.2024.100466
17. [17]
  Xinyu Hou , Xuelian Yu , Meng Liu , Hengxing Peng , Lijuan Wu , Libing Liao , Guocheng Lv . Ultrafast synthesis of Mo₂N with highly dispersed Ru for efficient alkaline hydrogen evolution. Chinese Chemical Letters, 2025, 36(4): 109845-. doi: 10.1016/j.cclet.2024.109845
18. [18]
  Zhen Zhang , Xue-ling Chen , Xiu-Mei Xie , Tian-Yu Gao , Jing Qin , Jun-Jie Li , Chao Feng , Da-Gang Yu . Iron-promoted carbonylation–rearrangement of α-aminoaryl-tethered alkylidenecyclopropanes with CO₂: Facile synthesis of quinolinofurans. Chinese Chemical Letters, 2025, 36(4): 110056-. doi: 10.1016/j.cclet.2024.110056
19. [19]
  Shuwen SUN , Gaofeng WANG . Design and synthesis of a Zn(Ⅱ)-based coordination polymer as a fluorescent probe for trace monitoring 2, 4, 6-trinitrophenol. Chinese Journal of Inorganic Chemistry, 2025, 41(4): 753-760. doi: 10.11862/CJIC.20240399
20. [20]
  Jinwei Zhang , Lipiao Bao , Xing Lu . Synthesis methodologies of conductive 2D conjugated metal-organic frameworks. Chinese Journal of Structural Chemistry, 2025, 44(4): 100459-100459. doi: 10.1016/j.cjsc.2024.100459

Get Citation

PDF

XML

Metrics

PDF Downloads(1)
Abstract views(710)
HTML views(9)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142